Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice

Table 5

Treatment strategies applied in the different groups.

	Surg	ch/RT/S	Chemo	RT	Supportive care	Stenting
Group 1A	17	4	2	5	0	3
Group 1B	9	5	1	1	0	1
Group 2	0	0	22	6	0	8
Group 3	0	0	0	0	55	32

Surg: surgery alone, ch/RT/S: neoadjuvant chemoradiation prior to surgery, chemo: chemotherapy alone, RT: radiotherapy alone.
One patient in group 1A was treated with endoscopic mucosal resection. One patient had preoperative chemotherapy alone. One patient in group 1B received a covered oesophageal expandable stent in order to seal an oesophageal perforation, prior to successful neoadjuvant therapy. Three patients in group 1A received endoscopic stenting because of local recurrence after successful initial treatment. Two patients in group 1B were treated with the combination of chemotherapy and radiotherapy.
Neoadjuvant chemoradiation consisted of radiation in a four-week schedule in combination with cisplatin 100 mg/m² and 5-FU 1000 mg/m².